The Economic Value of Vaccination: Why Prevention Is Wealth
1
Sanofi Pasteur MSD, Lyon, France
2
Sanofi Pasteur MSD, Maidenhead, United Kingdom
*
Author to whom correspondence should be addressed.
J. Mark. Access Health Policy 2015, 3(1), 29284; https://doi.org/10.3402/jmahp.v3.29284
Published: 12 August 2015
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
Theoretical and empirical evidence has demon- strated that health has a major role to play as a driver for economic growth [...]
Share and Cite
MDPI and ACS Style
Rémy, V.; Largeron, N.; Quilici, S.; Carroll, S. The Economic Value of Vaccination: Why Prevention Is Wealth. J. Mark. Access Health Policy 2015, 3, 29284. https://doi.org/10.3402/jmahp.v3.29284
AMA Style
Rémy V, Largeron N, Quilici S, Carroll S. The Economic Value of Vaccination: Why Prevention Is Wealth. Journal of Market Access & Health Policy. 2015; 3(1):29284. https://doi.org/10.3402/jmahp.v3.29284
Chicago/Turabian StyleRémy, Vanessa, Nathalie Largeron, Sibilia Quilici, and Stuart Carroll. 2015. "The Economic Value of Vaccination: Why Prevention Is Wealth" Journal of Market Access & Health Policy 3, no. 1: 29284. https://doi.org/10.3402/jmahp.v3.29284
